Irritable bowel syndrome is one of the most burdensome and chronic ailments with an estimated 45 million people affected in the United States, the International
The FDA approved nivolumab as part of combination therapy for certain patients with gastrointestinal malignancies.The approval applies to use of the agent with certain types
It has been well over year since the COVID-19 pandemic began, and all aspects of health care have been impacted in various ways.WHO’s goal to
Exercise provided considerable weight loss-independent benefits in patients with nonalcoholic fatty liver disease, according to research published in JHEP Reports.“Weight loss, as the result of
The Florida Gastroenterologic Society was originally conceived in 1965 by James L. Borland, M.D., a well respected Gastroenterologist who practiced in Jacksonville, Florida.